What’s in the rsv vaccine
Three distinct RSV vaccines authorized in recent years use different active ingredients: protein-based “prefusion F” antigens in Pfizer’s ABRYSVO and GSK’s AREXVY, and a nucleoside‑modified mRNA encod...
Your fact-checks will appear here
Efficacy of 2025-era influenza vaccines, including Moderna's mRNA-1010 and high-dose formulations
Three distinct RSV vaccines authorized in recent years use different active ingredients: protein-based “prefusion F” antigens in Pfizer’s ABRYSVO and GSK’s AREXVY, and a nucleoside‑modified mRNA encod...
do not encode an unmodified, wild-type viral spike sequence; manufacturers intentionally altered the spike open reading frame to improve stability and antigenicity — most notably by introducing prefus...
are now a global race: established mRNA pioneers and a growing roster of biotech firms in the , and are running more than a hundred clinical trials testing individualized neoantigen or tumor-antigen m...
Only one COVID-19 vaccine manufacturer—Pfizer/BioNTech—has been documented in these sources as having released key subject‑level trial data and broader review documents to regulators and, under court ...